Key facts
- This page summarizes Gerald E. Quirk's Form 4 filing for Syros Pharmaceuticals, Inc. (SYRS).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Oct 2024, 17:00.
Gerald E. Quirk - 30 Sep 2024 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)
- Reporting relationship
- Chief Legal & Compliance Offic
- Issuer ticker
- SYRS
- Reported as of
- 30 Sep 2024
- Net transaction value
- -$6,510
- SEC form
- 4
- Accepted by SEC
- 02 Oct 2024, 17:00:05 UTC
- Prior SEC filing
- 02 Apr 2024
- Next SEC filing
- 20 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Todd Rosenthal, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gerald E. Quirk filed Form 4 for Syros Pharmaceuticals, Inc. (SYRS) on 02 Oct 2024.
Change
- Previous filing in this sequence was filed on 02 Apr 2024.
- Current net transaction value: -$6,510.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SYRS
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +10,000
- Change %
- +25%
- Price
- Shares after
- 49,757
- Date
- 30 Sep 2024
- Ownership
- Direct
- Footnotes
- F1
SYRS
transaction
Common Stock
Tax liability
- Transaction value
- $6,510
- Shares
- -3,100
- Change %
- -6.2%
- Price
- $2.10
- Shares after
- 46,657
- Date
- 30 Sep 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SYRS
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 20,000
- Date
- 30 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents shares of common stock received upon vesting of a restricted stock unit award.
Footnote F2
Represents shares used to cover tax withholding on a restricted stock unit release.
Footnote F3
Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
Footnote F4
Represents a restricted stock unit award granted on September 12, 2023. These restricted stock units vested as to one third (1/3rd) of the shares underlying the award on September 30, 2024, and are scheduled to vest as to an additional one third (1/3rd) of such shares at the end of each successive year thereafter.